Intramuscular progesterone versus 8% Crinone vaginal gel for luteal phase support for day 3 cryopreserved embryo transfer

Luteal support with 8% Crinone was associated with lower odds of clinical pregnancy and live birth compared with intramuscular progesterone in a multivariable analysis of day 3 cryopreserved embryo transfer cycles.

Like Comment

Authors

Daniel J. Kaser, M.D., Elizabeth S. Ginsburg, M.D., Stacey A. Missmer, Sc.D., Katharine F. Correia, M.A., Catherine Racowsky, Ph.D.

Volume 98, Issue 6, Pages 1464-1469, December 2012

Abstract

Objective:

To compare outcomes following intramuscular 84 progesterone (IMP) or 8% Crinone vaginal gel for luteal support for day 3 cryopreserved embryo transfer (CET).

Design:

Retrospective cohort study with multivariable analysis.

Setting:

Academic medical center.

Patients:

All autologous and donor egg IVF and ICSI patients who had a day 3 CET between January 1, 2008 and April 30, 2011 with luteal support using IMP 25-50 mg/d or Crinone 8% twice daily, initiated 3 days before the CET.

Interventions:

None.

Main outcome measures:

Implantation rate, clinical pregnancy and live birth rates per CET.

Results:

IMP (n=440) and Crinone (n=298) recipients were similar for all demographic characteristics and cycle parameters assessed. While implantation rates did not differ significantly for the two progesterone groups (Crinone vs. IMP: 19.6% vs. 30.4%), women supplemented with Crinone had significantly lower rates of clinical pregnancy (36.9% vs. 51.1%) and live birth (24.4% vs. 39.1%) compared with those on IMP.

Conclusions:

We observed that Day 3 CET cycles with Crinone 8% luteal support have a 44% and 49% lower odds of clinical pregnancy and live birth, respectively, compared to those with IMP support. Further studies are required to identify the optimal timing and dose of Crinone 8% vaginal gel for use in CET cycles.

Read the full text at: http://www.fertstert.org/article/S0015-0282(12)02059-6/fulltext


Go to the profile of Fertility and Sterility

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.

No comments yet.